<DOC>
	<DOCNO>NCT02479997</DOCNO>
	<brief_summary>This study aim compare detection rate dual sentinel node stain method use mixture indocyanine green ( ICG ) radioisotope ( RI ) , RI . To identify first lymph node ( ) along lymphatic drainage pathway primary tumor breast cancer use RI several disadvantage invisibility , interference . As ICG visualize fluorescence imaging system , expect dual sentinel lymph node stain method well outcome .</brief_summary>
	<brief_title>Clinical Application Dual Sentinel Lymph Node Staining Method Breast Cancer Patients</brief_title>
	<detailed_description>Using mixture indocyanine green ( ICG ) radioisotope ( RI ) guide surgeon identify first lymph node ( ) along lymphatic drainage pathway primary tumor breast axillary lymph node basin . Last pilot study , sentinel lymph node successfully identify use dual method ICG RI 5 patient . In study , radiolabeled colloid use , gamma probe identifies radioactivity lymph node axilla . If ICG , RI use , Near infrared fluorescence camera visualize surgery . As investigator measure node detection time axillary approach moment , investigator go compare detection rate . ( ICG+RI RI ) . And determine accuracy . Sentinel lymph node map ICG radiolabeled colloid mapping agent recommend maximize likelihood SLN identification minimize possibility miss SLNs , could result false-negative event.The protocol require 130 patient receive neoadjuvant chemotherapy . In study investigator expect use mixture indocyanine green ( ICG ) radioisotope ( RI ) potential improve sentinel lymph node ( SLN ) map breast cancer patient receive neoadjuvant chemotherapy . Sentinel lymph node map ICG radiolabeled colloid mapping agent recommend maximize likelihood SLN identification minimize possibility miss SLNs , could result false-negative event .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>breast cancer patient receive neoadjuvant therapy ( chemotherapy , hormonal therapy , target therapy ) cN1cN2 cN3 ( must complete response status ) tumor lymphnode metastasis classification ( TNM ) neoadjuvant therapy . ECOG Performance status 0 1 consent patient 20 year , less 70 year history breast cancer early stage breast cancer history excisional incisional biopsy axillary dissection inflammatory breast carcinoma cN3 tumor lymphnode metastasis classification ( TNM ) stage 4 breast cancer pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Neoadjuvant chemotherapy</keyword>
	<keyword>Indocyanine green ( ICG )</keyword>
	<keyword>Radioisotope ( RI )</keyword>
	<keyword>Near infrared fluorescence camera</keyword>
</DOC>